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India has come alive to the need for recognition and protection of intellectual property. In 
post GATT regime, India has transformed from purely agricultural to agricultural-cum-
industrially developed nation. The Industrial progress of a country generally depends upon 
inventive talents of the entrepreneurs and the number of invention made by them. There is a 
no doubt that India became member to the Uruguay Round of Multilateral Trade Negotiations 
and also agreement of Trade Related Aspects of Intellectual Property Rights (TRIPS) is a 
part of the agreements establishing WTO from GATT and India ratified such agreements. 
This research article express importance of Intellectual Property Rights with special 
reference to neem products have been patented and some controversial patents on neem. 
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Introduction 
The neem tree (Azadirachta indica) originates from the 
Indian sub-continent and now grows in the dry regions of more 
than 50 tropical countries around the world. Generally, its 
properties are used to cure common colds and flu. The oil 
extracted from its seeds can be used to cure various diseases. 
Mixed in soap, it offers cheap and easy relief from malaria, skin 
diseases and even meningitis. It is mentioned in Indian texts 
written over 2000 years ago and has been used for centuries 
by local communities in agriculture as an insect and  pest 
repellent, in human  and veterinary medicine, toiletries and 
cosmetics. It is also venerated in the culture, religions and 
literature of the region. 
 Even though first report on pesticide property of neem 
was reported in India in 1928, only after 30 years later 
systematic research work on neem was initiated. The past five 
decades witnessed intensive investigation and upward trend to 
scientific interest on neem and its diverse properties, resulting 
in large number of research publications, books and 
conferences at national and international levels. It led to 
isolation and identification of more than 140 compounds, from 
various parts of the plant [1-5]. It showed anti-inflammatory [6], 
anti-ulcer [7-10], antimalerial [11,12], antifungal [13-17], 
antibacterial [18], antiviral [19-23], antioxidant, antimutagenic 
and  anticarcinogenic activity [24-26]. It also exhibited 
impeccable insecticidal property which found its applications in 
pesticide [27]. Neem extracts can be used against over 250 
pests including whiteflies, aphids, mealybugs, mites, and 
termites. It is also effective against fungal diseases such as 
rusts and powdery mildew that attack the leaves of ornamental 
plants and food crops, medical, healthcare and cosmetic 
industry all over the world [28]. 
 In the post GATT era, when India is a signatory to the 
TRIPs agreement and is a member of WTO, intellectual 
property rights (IPRs) are being considered as a tool to create 
wealth through knowledge. The TRIPs agreements on one 
hand, and restrictions on dual use technology, marketing, 
territorial restrictions and non-tariff barriers on another hand 
have thrown many challenges and opportunities for scientist 
and industrialists. The major challenge is in the area of IPR 
which has lead to its recognition of importance by the R&D and 
to industrial organizations. After signing of TRIPs agreements, 
awareness about the importance of IPR has grown 
tremendously since 1994. It is essential to understand the 
importance of IPR, why to protect IPR and its importance in 
technology development. Such issues are discussed in this 
paper with special reference to neem patents. 
 IPR is concerned with the intangible property, it may be 
called as Intangible Property Rights; as industrialists are 
concerned with IPRs mainly in the context of exclusive 
protection and rights for their investment, so one may call it a 
Investment Protection Rights too, however its correct 
connotation is Intellectual Property Rights. 
The TRIPs agreement deals with seven areas of IPR: 
Patents  
Industrial designs  
Copyright and related rights  
Trademarks  
Geographical indications 
Layout designs of integrated circuits. 
Protection of undisclosed information. 
Protection of IPR 
Today we are living in an extremely competitive world 
where the technology is ever changing. New and improved 
technology are being developed at a very fast rate than ever 
before. Here one may raise the question that when the 




technology is said to be ever changing/improving, then why do 
we need to go for safeguarding the IPRs. This is mainly due to 
the desire of the inventor to have exclusive rights/monopoly 
over the advancements made in technology and at the same 
time to exclude others from exploiting the same for commercial 
benefits. The awareness of exclusive rights to the original 
inventor(s) and penalty/punishment to infringer of such rights 
are the basis for the creation of IPR related laws. 
Further, safeguarding the IPR ensures better returns on 
inputs of the R&D efforts. It is observed that the development 
of a new technology is often followed by the challenge to utilize 
it or to transfer it for commercial exploitation. The utilization or 
transfer of technology is faced by another challenge i.e. how to 
avoid unauthorized copying and use so that the hard inputs 
e.g. intellectual and financial, are not wasted without 
appropriate returns. The only means to meet the challenge of 
avoiding the unauthorized copying or use of the technology is 
to safeguard the technology by IPR instruments. In today’s 
world it is understood the protection of one’s IPR is mainly to 
safeguard exclusive rights/monopoly, but actually it gives 
exclusive rights to use, manufacture, sell etc. only for a limited 
period of time. Such exclusive rights/monopolies for a limited 
period of time are the main reasons for one to go for protection 
of one’s IPR. 
The appropriate returns come only if the invention is kept 
secret by means of trade secret or is safeguarded by securing 
IPR. If the invention is kept secret by means of trade secret, 
there is every chance of disclosure of information to the third 
party. Once the information is disclosed, then one cannot 
expect returns of his/her inputs. But if the invention is 
safeguarded by securing the IPR then the risk due to 
disclosure is totally eliminated, because the information is 
published by the government itself in the form of patent 
document and, in return, the government grants the exclusive 
rights/monopoly. 
The exclusive rights/monopoly was granted by the 
government only if the invention meets the criteria of award of 
such rights. Therefore, one should take care that the invention 
is not made known to public by way of demonstration, 
exhibition, publication or use within the country or elsewhere 
before the date of filing the patent application. 
Importance of IPR in Technology Development  
The protection of technology from piracy and 
counterfeiting is increasingly becoming important for industrial 
investment specially in technology sensitive sectors or where 
the technology is R & D intensive, such as, information 
technology, defence sectors etc. This becomes more important 
because the investment required in bringing research activities 
to the industrial applications and/or market stage has already 
arisen vary high. In the presence of IPR system the protection 
of intellectual properties, which particularly means the 
protection of knowledge, research and development for 
industrial investments, becomes possible due to the reasons 
stated above. The new technological information disclosed in 
the patent document plays a vital role in the technological 
development. Therefore, such disclosure of inventions, in 
return of grant of exclusive rights/ monopolies by one may help 
others in the development of new technology by way of 
providing solution to the ongoing technical problems. 
Measures of Intellectual Property  
Trade Measures 
The trade measures that are most relevant to the neem 
tree case are intellectual property and patents. United States 
patents on neem tree products are seen as forms of “biopiracy” 
by country of India, the Green Party and the European Patent 
Office. There are three main issues surrounding the patenting 
of local products used for medicinal or agricultural purposes by 
the United States. First, the farmers will no longer be able to 
use these products without paying royalties to the company 
that has a patent on it. Secondly, consumers will be deprived 
of cheap medicines and agriculture products. Last, local 
communities should receive a share of the profits because the 
companies learned the value of the species from local 
knowledge. 
Since 1985, over a dozen of the U.S. patents by the 
United States and Japanese firms are for the neem-based 
solutions and emulsions. There are a total of four patents are 
owned by W.R. Grace. Three patents are owned by another 
U.S.  Company, the Native Plant Institute. Two others own by 
the Japanese company, Terumo corporation. Remember that 
these patents are used for the process of making the emulsion 
from the neem tree, not on the need tree itself. The US 
Company had in fact created a new invention from the neem 
extraction process. The local population, however, has been 
extracting the substance from the seeds for years, too, using a 
more traditional method of  “smashing the seeds” and 
“scooping the emulsion.” 
The neem is not only living organism that has become a 
subject of “patent” debate. There are scientists and farmers 
around the world that are trying to gain rights to protect their 
organisms. For example the Africa Soapberry has properties 
for insecticidal soap, fish intoxicant and a  spermicidal 
contraceptive that African have used for a very long time. In 
1964, though,’ things changed due to Dr. Akililu Lemma’s 
report to the Tropical Products Institute in Britain that it killed 
water snails (which are used to fight the disease, bilharzias). At 
the time of his report, he was stunned to find out that the 
Institute placed a patent on the extraction process without 
consulting or crediting him [29].  
Legal Groups of Patentalization 
The World Trade Organization (WTO) is encouraging 
developing countries to expand their legal protection of 
intellectual property rights in order to be on a similar “playing 
field” with the developed countries. In an effort to standardize 
trade rule, the WTO is also asking developing countries to 
open up top foreign direct investment from abroad and to 
liberalize their trade policies. The WTO believes that the 
restructuring will lead to a development of more modern 
economies. 
There has been a restructuring of the General Agreement 
on Tariffs and Trade (GATT) into the WTO. This resulted in 
agreements on Trade-Related Aspects of Intellectual Property 
forum for dispute, created a trend towards a legal framework of 
patent rights [29]. According to Shiva, “the northern countries 
argued that when southern farmer’s attempted to retain free 
use of their own seeds,  developed by them over thousands of 
years, it was a form of piracy, but the pirate’s hat clearly 
belongs on the other head” [29]. 




One of the major parties involved is obviously the Indian 
government who has signed onto the TRIPs agreement. India’s 
laws still do not allow patents on agricultural and 
pharmaceutical products. Another party involved is the 
business community (like W.R. Grace) that needs intellectual 
property rights to encourage development in foreign countries 
because it gives more incentive to the business owners that 
their property or “inventions” will be protected. They believe 
that the result of researching and development in foreign 
countries can lead to a greater public good because of the new 
discoveries of medicines and other innovations that will result. 
Another forum for dispute surrounding the neem tree is 
the Convention on Biological Diversity (CBD) that took place in 
1992 at the United Nations Conference on Environment and 
Development. Article 15 of the convention states bio-assets 
are the property of the sovereign states in which they are from. 
In other words, they are not the property of the world at large. 
India’s claim is that what the Western world is calling 
discoveries is actually an indigenous method that they have 
been suing for years. They say that it is a bioassets that is 
protected under Article 15 of the convention. While CBD 
emphasizes the rights of sovereign nations over biological 
resources, such as the neem tree, it still calls  for the 
acceptance of intellectual property rights. What this means is 
the CBD calls for governments, such as India, to provide  the 
proper patents or other forms of protection on the life forms 
and include pharmaceutical products.  
On the other hand, WTO dispute that relates to the TRIPs 
agreement is a case that involves India, as well. This case is 
regarding Basmati rice. India feels that because the United 
States has granted a patent for Basmati rice, that it is violating 
the TRIPs agreement. They say that Basmati rice is exclusively 
associated with India and Pakistan. They want the United 
States to take away their patent on the rice because they felt it 
is an indigenous product of their country. India’s problem with 
the neem tree is similar to the Basmati case because they 
have realize the importance for creating laws that conserve 
bio-assets and control piracy. They feel that protecting their 
assets through patents may protect them from other 
companies like Rice Tec that took advantage of the 
nonexistent Indian laws. Indian farmers want to protect their 
cultural heritage. It seems the best way to do it is to change 
their philosophical attitude that natural resources should not be 
patented in order to protect and preserve India’s biodiversity 
and also to conform to international laws and agreements like 
the TRIPs agreement. According to Shiva, there has been a 
new alliance of farmers and scientists to formulate an 
alternative form of intellectual property rights–what they  term 
collective intellectual property rights (CIPR’s) [29]. It allows 
people to have the right to benefit commercially from traditional 
knowledge. In other words,  the farmers wnt to solve their 
disputes at the local level or village organizations rather than 
through GATT panels. 
Neem Patents 
Since the 1980s, many neem related process and 
products have been patented in Japan, USA and European 
countries. The first US patent was obtained by Terumo 
Corporation in 1983 for its therapeutic preparation from neem 
bark. In 1985 Reobert Larson from (USDA) obtained a patent 
for his preparation of neem seed extract and the Environmental 
Protection Agency approved this product for use in US market. 
In 1988 Robert Larson sold the patent on an extraction process 
to the US Company W.R. Grace (presently Certis). 
In 1990 patent is for a method of producing neem extract 
that can be stored well. The abstract says: “Storage stable 
pesticide compositions comprising neem and extracts which 
contain azadirachtin as the active pesticidal ingredient wherein 
the compositions are character sized by their non-degrading 
solvent systems. In a first embodiment, the pesticide 
compositions contain solvent systems character sized as 
having greater than 50% by volume aprotic solvents and less 
that 15% by volume water. In a second embodiment, the 
pesticide compositions contain solvent systems characterized 
as having greater than 50% by volume alcohol and less than 
5% by volume water. The pesticide compositions contain 
surfactant concentrations of at least about 1.0%, up to 10%.” 
In 1994 patent is for a specific method of extracting and 
treating active substances from neem seeds so that the 
resulting solution is stable enough to store. The abstract says 
the patent is for a “process for the production of stable 
azadirachtin solutions comprising extracting ground neem 
seeds with a solvent having azadirachtin extract solution and 
then adding an effective amount of 34 Angstrom molecular 
sieves to selectively remove water from the extract to yield a 
storage-stable azadirachtin solution having less than 5% water 
by volume”. 
It is only these specific newly invented processes that are 
covered by the patents. Farmers always have and will continue 
to be free to use neem in any traditional way they desire. The 
use of neem extract, or its seeds or leaves, cannot be 
patented, since they have been used for centuries. Its 
properties can only be patented if they are considerably 
modified. For instance, any synthetic variation of a naturally 
occurring product is patentable, as it does not occur in nature 
in that form. 
Having gathered their patents and clearance from the 
EPA, four years later, Grace commercialized I ts product by 
setting up manufacturing plant in collaboration with P.J. Margo 
Pvt. Ltd. In India and continued to file patents from their own 
research in USA and other parts of world.  Aside from Grace, 
neem based pesticide were also marketed  by another 
company, AgriDyne Technologies Inc., USA, the market 
competition between the two companies was intense. In 1994,  
Grace accused AgriDyne a non-exclusive royalty-bearing 
license. During this period in Indian large number of companies 
also developed stabilized neem products and made them 
available commercially. The number of patents filed in this 
period were limited and geographically confined to few 
countries. 
According to Rekhi [30], one hundered seventy one (171) 
product of neem have been patented till now which are given 
below as: 
Total Patents on Neem   
United States  54 
Japan   59 
Germany           05 
EPO            05 
Great Britain   02 
India            36 
PCT            10 




(Austria, Belgium, Denmark, Ireland, France, Greece, etc.) 
Total   171 
Dispute Matter on Neem Patentalization 
There is an increasing awareness in India of the co 
modification of neem will lead to the expropriation by 
multinational corporations, like W.R. Grace [31]. On Indian 
Independence Day in 1995, farmers in from Karnataka rallied 
outside the district office to challenge the demands for made 
by multinational corporations for intellectual property rights. As 
part of their protest, the farmers carried twigs and branches 
from the neem tree as a symbol of their collective indigenous 
knowledge of the properties of the neem [31].  
The United States, on the other hand, states that what 
they are doing will help the Indian economy. India is not 
against sharing its information about the Neem tree’s virtues, 
but it is against countries and corporations that intend to stop 
India’s present use of it.  
Another issue is whether the neem tree is patentable, 
since it is a product of nature, which shows that it is not a result 
of innovation and discovery. The problem is that W.R. Grace 
does not have a patent on the tree itself, but rather on the 
process of making the emulsion. They believe that this process 
is a discovery because it entails manipulation yielding greater 
and better results. In other words, discovery seems to have 
both old and new definitions. The problem is over the use of 
novel scientific advances on traditional Indian techniques. 
According and Natural Resource Policy in India, “Corporate 
processes are supposedly novel advances on Indian 
techniques” [31]. She goes on to state that the reluctance of 
scientists in India to patent agricultural and pharmaceutical 
inventions may be a result of their recognition that the bulk of 
work had already been accomplished by generations of 
anonymous, Indian experimenters, for example, Dr. R.P. Singh 
of the Indian Agricultural Research Institute asserts: 
“Margosan-O is a simple ethanolic extract of neem seed 
kernel. In the late sixties we discovered the potency of not only 
ethanolic extract, but also other extracts of neem [32, 33]. 
Work on the neem as pesticide originated from this divisions as 
early as 1962. Extraction techniques were also developed in a 
couple of years. The azadirachtin – rich dust was developed by 
me” [34]. Shiva also states that the discovery of the neem’s 
properties and the means of processing the extract was not 
“obvious” but rather evolved through extended systematic 
development in non-western cultures. 
The World Trade Organization (WTO) is asking 
developing countries to open up to foreign direct investment 
from abroad to liberalize their trade policies. There has been a 
restructuring of general agreement on Tariffs and Trade 
(GATT) into the WTO. This resulted in agreements on trade-
related aspects of intellectual property rights (TRIPs) made 
during the Uruguay Round. These agreements created a trend 
towards a legal frame work for intellectual property rights 
including a consensus to follow and establish patent laws in 
conjunction with those of the developed world. 
While this can be seen as a good sign for India, it still 
causes a problem because of the Indian government’s 
reluctance to issue patents on agricultural and pharmaceutical 
product. Also, there is a lack of knowledge of the legal  process 
that surrounds intellectual property rights. Indian business 
owners argue that the lack of patents leads their technology to 
move to the developed world India feels that by letting foreign 
companies control resources, they become more vulnerable to 
them.  As a result, there has been a backlash on foreign 
investment and less joint ventures between India and United 
States. 
Controversial Patents on Neem 
US patent No. 4946681 – granted in 1990 for improving 
the storage stability of neem seed extracts containing 
azadirachtin (a naturally occurring substances that belongs to 
an organic molecule class called triterpenoids. Azadirachtin 
occurs in all parts of the neem tree but the majority of it is 
concentrated in the neem Kernal. It is one of more than 70 
limonoids produced by neem). The inventor is named as 
James F Walter of Ashton, Maryland. 
US patent No. 5124349 – granted in 1992 for storage of 
stable insecticidal composition comprising neem seed extract. 
The major contribution was increasing the shelf-life stability of 
azadirachtin solution (Four people are named as the 
inventors). 
Recent Indian Patents on Neem 
70/BOM/91-13.3.91 (171888)– A process for treating 
(Upgrading) Neem Oil – Hindustan Lever Ltd., Bombay, India. 
668/Mas/93 – 23.3.903– A combination of hydroponicum 
and a spray to improve the survival of tissue cultured plants 
with specific references to Neem – Dalmia Centre of 
Biotechnology. 
757/Del/93 – 20.7.93- Preparation of edible Neem oil – 
Rohm and Hass Co. 
758 Del/93 – 20.7.93- Stable extract from neem oil – 
Rohm and  Hass Co. 
759/Del/93 – 20.7.93- Preparation of neem seed extract – 
Rohm and Hass Co. 
1270, 1271, 1272 & 1273/ Del/93– 12.11.93- A process 
for preparation of a spermicidal agent from neem oil or 
extractives – National Research Development Corporation. 
7/Mas/94– 7.1.94– A Method for preparing ayurvedic 
antivrus compound comprising three oils mainly neem seed oil 
– Girivas Vishwanath Seth. 
9/Mas/94– 10.1.94– Nimbecidine – Vegetable oil including 
neem oil, enriched with azadirachtin and the same extracted 
from neem seed and other parts of neem-T. Stanes and 
Company Ltd. 
1397/Del/93-  9.12.93– A method for producing 
azadirachtin – Rohm and Hass Co. 
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